Our centers of expertise span therapeutic areas, markets and geographies, and are underpinned by these four core research principles:
The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US.
Download this summary report to find out about therapies in clinical development, efficacy rates, and unmet needs for on Alzheimer’s disease.
Understand how best to engage with and support imaging centres and radiologists to ensure they are integrated in the Alzheimer’s disease care pathway.
The shock early June approval of Biogen’s Aduhelm (aducanumab) for the treatment of Alzheimer's disease by the FDA through its accelerated approval.
Rapport is our monthly newsletter where we share our latest expertise and experience.
